Hypermethylation and Post-Transcriptional Regulation of DNA Methyltransferases in the Ovarian Carcinomas of the Laying Hen

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lee, Jin Young ^a   Jeong, Wooyoung ^a   Lim, Whasun ^a   Lim, Chul Hong ^a   Bae, Seung Min ^a   Kim, Jinyoung ^b   Bazer, Fuller W ^a,c   Song, Gwonhwa ^a  

^a Seoul National University   (South Korea)

^b Dankook University   (South Korea)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MICRORNA; MICRORNA 1632; MICRORNA 16C; MICRORNA 1741; MICRORNA 222; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; DNA METHYLATION; DNMT1 GENE; DNMT3A GENE; DNMT3B GENE; EGG LAYING; ENZYME REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HEN; NONHUMAN; OVARY CARCINOMA; PROMOTER REGION; STROMA CELL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CHICKENS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICRORNAS; OVARIAN NEOPLASMS; OVARY; OVIPOSITION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

ANIMALIA; AVES; MAMMALIA; MUS;

EID: 84876270654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061658     Document Type: Article

References (34)

1. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Fathalla MF, (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2: 163.
3. Smith ER, Xu XX, (2008) Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelial ovarian cancer involving follicle depletion. Lancet Oncol 9: 1108-1111.
4. Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, et al. (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19: 531-539.
5. Vanderhyden BC, Shaw TJ, Ethier JF, (2003) Animal models of ovarian cancer. Reprod Biol Endocrinol 1: 67.
6. Stakleff KD, Von Gruenigen VE, (2003) Rodent models for ovarian cancer research. Int J Gynecol Cancer 13: 405-412.
7. Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, et al. (2008) Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 109: 115-121.
8. Jaenisch R, Bird A, (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33Suppl: 245-254.
9. Laird PW, (2010) Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 11: 191-203.
10. Lan J, Hua S, He X, Zhang Y, (2010) DNA methyltransferases and methyl-binding proteins of mammals. Acta Biochim Biophys Sin (Shanghai) 42: 243-252.
11. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, et al. (1999) The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298.
12. Socha MJ, Said N, Dai Y, Kwong J, Ramalingam P, et al. (2009) Aberrant promoter methylation of SPARC in ovarian cancer. Neoplasia 11: 126-135.
13. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee I, et al. (2006) De novo CpG island methylation in human cancer cells. Cancer Res 66: 682-692.
14. Jones PA, Baylin SB, (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428.
15. Jackson E, Anderson K, Ashwell C, Petitte J, Mozdziak PE, (2007) CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. Gynecol Oncol 104: 192-198.
16. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE, (2001) Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81: 373-379.
17. Anderson GL, McIntosh M, Wu L, Barnett M, Goodman G, et al. (2010) Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study. J Natl Cancer Inst 102: 26-38.
18. Johnson KA, (2009) The standard of perfection: thoughts about the laying hen model of ovarian cancer. Cancer Prev Res (Phila) 2: 97-99.
19. Jones PA, Takai D, (2001) The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070.
20. Robertson KD, (2002) DNA methylation and chromatin- unraveling the tangled web. Oncogene 21: 5361-5379.
21. Kurihara Y, Kawamura Y, Uchijima Y, Amamo T, Kobayashi H, et al. (2008) Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1. Dev Biol 313: 335-346.
22. Li E, Bestor TH, Jaenisch R, (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
23. Stec I, Nagl SB, van Ommen GJ, den Dunnen JT, (2000) The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett 473: 1-5.
24. Okano M, Bell DW, Haber DA, Li E, (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
25. Esteller M, (2007) Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16 Spec No 1: R50-59.
26. Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, et al. (2008) Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. J Urol 179: 346-352.
27. Roa JC, Anabalon L, Roa I, Tapia O, Melo A, et al. (2005) [Promoter methylation profile in gastric cancer]. Rev Med Chil 133: 874-880.
28. Yang HJ, Liu VW, Wang Y, Tsang PC, Ngan HY, (2006) Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer 6: 212.
29. Suzuki MM, Bird A, (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465-476.
30. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM, (2006) MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587.
31. Lim W, Kim JH, Ahn SE, Jeong W, Kim J, et al. (2012) Avian SERPINB11 gene: a marker for ovarian endometrioid cancer in chickens. Exp Biol Med (Maywood) 237: 150-159.
32. Lee JY, Jeong W, Lim W, Kim J, Bazer FW, et al. (2012) Chicken pleiotrophin: regulation of tissue specific expression by estrogen in the oviduct and distinct expression pattern in the ovarian carcinomas. PLoS One 7: e34215.
33. Song G, Spencer TE, Bazer FW, (2006) Progesterone and interferon-tau regulate cystatin C in the endometrium. Endocrinology 147: 3478-3483.
34. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.